Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosage Optimization for Letrozole Treatment in Clomiphene Resistant Patients With Polycystic Ovary Syndrome: A Prospective Interventional Study

NCT01315912 is registered in ClinicalTrials.gov with Bushehr University of Medical Science as lead sponsor.

NCT NCT01315912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01315912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosage Optimization for Letrozole Treatment in Clomiphene Resistant Patients With Polycystic Ovary Syndrome: A Prospective Interventional Study
Lead sponsor
Bushehr University of Medical Science
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2010
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility